Value
—- Trailing PER (last 12 months)
- —
- Last four quarters not verified
Insufficient data
VRAX
Virax Biolabs Group Limited
VRAX
Virax Biolabs Group Limited
$ 1.3
-
Insufficient data
Insufficient data
Insufficient data
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.
| Asset | Price | Div. Yield |
|---|